79 related articles for article (PubMed ID: 21073045)
1. Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Poh R; Muniandy S
Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1231-46. PubMed ID: 21073045
[TBL] [Abstract][Full Text] [Related]
2. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Jornayvaz FR; Brulhart-Meynet MC; James RW
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
[TBL] [Abstract][Full Text] [Related]
4. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Voorbij HA; Sluiter WJ; van Tol A
Eur J Clin Invest; 2009 Mar; 39(3):200-3. PubMed ID: 19260949
[TBL] [Abstract][Full Text] [Related]
7. Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.
Beer S; Moren X; Ruiz J; James RW
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):457-65. PubMed ID: 17015182
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in PON1 activities, PON1 phenotype distribution and oxidative status throughout normal pregnancy.
Stefanović A; Ardalic D; Kotur-Stevuljević J; Vujović A; Spasic S; Spasojević-Kalimanovska V; Jelic-Ivanovic Z; Mandic-Markovic V; Mikovic Z; Cerovic N
Reprod Toxicol; 2012 Jan; 33(1):20-6. PubMed ID: 22074696
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
10. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M
Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia.
Türkeli H; Caycı T; Akgül EÖ; Macit E; Yaman H; Aydın I; Demirin H; Alacam H; Ozkan E; Cakır E; Deren O; Erbil MK; Kunak ZI; Burat K; Akman S
Int J Cardiol; 2010 Nov; 145(1):42-3. PubMed ID: 19419786
[TBL] [Abstract][Full Text] [Related]
12. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.
Ikeda Y; Inoue M; Suehiro T; Arii K; Kumon Y; Hashimoto K
Acta Diabetol; 2009 Sep; 46(3):239-42. PubMed ID: 18830558
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).
van den Berg SW; Jansen EH; Kruijshoop M; Beekhof PK; Blaak E; van der Kallen CJ; van Greevenbroek MM; Feskens EJ
Diabet Med; 2008 Feb; 25(2):186-93. PubMed ID: 18290860
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
[TBL] [Abstract][Full Text] [Related]
15. Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease.
Sarkar PD; T M S; Madhusudhan B
Clin Chim Acta; 2006 Nov; 373(1-2):77-81. PubMed ID: 16797516
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
18. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
20. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
